Audiologists in Libertyville, IL Accepting Medicare

12 Audiologists found. Showing 1 - 12

Ms. Dana Ramsey, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 606 S Milwaukee Ave, Unit B, Libertyville, IL 60048 Phone: 708-638-4256

Ms. Alicia L Alexander, CCC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1512 Artaius Pkwy Ste 200, Libertyville, IL 60048 Phone: 847-573-0073    Fax: 847-573-8660

Jan Mcdonnell, M.A. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 850 S Milwaukee Ave, Libertyville, IL 60048 Phone: 847-549-8200

Connect Hearing, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1470 S Milwaukee Ave, Libertyville, IL 60048 Phone: 630-303-5380    Fax: 630-303-5385

Mrs. Natalie Rubin, M.S., CCC-A Audiologist Medicare: Medicare Enrolled Practice Location: 1470 S Milwaukee Ave, Libertyville, IL 60048 Phone: 847-573-0073

Linda Stanton Remensnyder, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 755 S Milwaukee Ave, Suite 189, Libertyville, IL 60048 Phone: 847-680-7580    Fax: 847-680-9168

Mrs. Caryn Alison Kedzierski, M.A., CCC-A Audiologist Medicare: Accepting Medicare Assignments Practice Location: 1880 Winchester Road, Suite 103, Libertyville, IL 60048 Phone: 847-816-1116    Fax: 847-438-2633

Audionova Llc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1470 S Milwaukee Ave, Libertyville, IL 60048 Phone: 847-573-0073    Fax: 630-303-5385

Hearing Associates Pc Audiologist Medicare: Not Enrolled in Medicare Practice Location: 755 S Milwaukee Ave, Suite 189, Libertyville, IL 60048 Phone: 847-680-7580    Fax: 847-680-9168

Mrs. Carly Jean Girard, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 755 S. Milwaukee Ave., Ste. 189, Libertyville, IL 60048 Phone: 847-680-7580    Fax: 847-680-9168

Best Hearing Of Libertyville Audiologist Medicare: Not Enrolled in Medicare Practice Location: 1880 W Winchester Rd, Suite 103, Libertyville, IL 60048 Phone: 847-816-1116

Jaime Block, AUD Audiologist Medicare: Not Enrolled in Medicare Practice Location: 890 Garfield Ave Ste 106, Libertyville, IL 60048 Phone: 847-367-7470

News Archive

Xencor and CSL Limited establish antibody optimization collaboration

Xencor, Inc., an antibody discovery and development company, announced today that it has entered into an antibody optimization collaboration with CSL, Ltd. The collaboration will provide CSL with access to Xencor's XmAb technology platform to enhance the ADCC effector function of its therapeutic antibodies.

CRISPR-based engineered cell lines can accelerate potential treatment targets for SARS-CoV-2

Synthego, the genome engineering company, has collaborated with The Krogan Lab, a world-renowned scientific research unit at the Quantitative Biosciences Institute (QBI) at the University of California, San Francisco (UCSF), to deliver multiple CRISPR-based engineered cell lines to accelerate the study of potential treatment targets for SARS-CoV-2, the novel coronavirus that causes COVID-19 disease.

UAB study shows how ion channel differentiates newborn and mature neurons in the brain

The dentate gyrus of the hippocampus is part of the brain that helps form memories. It is also one of just two areas in the adult brain where new neurons are continuously formed.

Research finds variability in PTSD symptoms over the course of menstrual cycle

In women who have experienced trauma, post-traumatic stress disorder symptoms may vary over the course of the menstrual cycle, with more symptoms during the first few days of the cycle when the hormone estradiol is low, and fewer symptoms close to ovulation, when estradiol is high, finds research published by the American Psychological Association.

Promising results from Exelixis' cabozantinib phase 2 trial against metastatic ovarian cancer

Exelixis, Inc. reported longer follow-up data from a fully enrolled cohort of patients with advanced epithelial ovarian cancer, primary peritoneal carcinoma, or fallopian tube carcinoma treated with cabozantinib (XL184) in an ongoing phase 2 adaptive randomized discontinuation trial. Cabozantinib shows promising activity in these patients independent of prior response to platinum-based therapies.

Read more Medical News

› Verified 8 days ago